HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carboxypeptidase G2 rescue after high-dose methotrexate.

AbstractPURPOSE:
This study was a pilot project to assess the safety and efficacy of carboxypeptidase G2 (CPG2) rescue from high-dose (HD) methotrexate (MTX) in patients with recurrent cerebral lymphoma.
PATIENTS AND METHODS:
Four patients with recurrent primary CNS lymphoma (PCNSL) were studied. Patients received 3.0 g/m2 MTX infused over 2 hours. Twelve hours after the start of MTX, 50 U/kg CPG2 was infused; a second dose of CPG2 was given 6 hours after the first. Blood and CSF were collected and assayed for levels of MTX, CPG2, and 2,4-diamino-N10-methylpteroic acid (DAMPA), a cleavage product of MTX after CPG2. Serum was collected for at least 2 weeks after administration of MTX-CPG2 to assess anti-CPG2 activity antibodies.
RESULTS:
All patients had at least a 2-log decline in plasma MTX levels to the subtherapeutic range within 5 minutes of CPG2 administration. The second dose of CPG2 did not further diminish the already low plasma MTX level. DAMPA appeared and was detected as the plasma MTX concentration decreased. CSF MTX concentration remained elevated for 4 hours after CPG2, and its decline followed first-order kinetics. Anti-CPG2 activity antibodies were not detected in any patient. No MTX or CPG2 toxicity was observed.
CONCLUSION:
CPG2 rescue is a safe, effective alternative to leucovorin rescue after HD MTX and may prove particularly useful for the treatment of MTX-sensitive CNS tumors, as it does not affect CSF MTX levels.
AuthorsL M DeAngelis, W P Tong, S Lin, M Fleisher, J R Bertino
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 14 Issue 7 Pg. 2145-9 (Jul 1996) ISSN: 0732-183X [Print] United States
PMID8683248 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antimetabolites, Antineoplastic
  • deoxyaminopteroic acid
  • gamma-Glutamyl Hydrolase
  • Methotrexate
Topics
  • Antimetabolites, Antineoplastic (administration & dosage, adverse effects, pharmacokinetics)
  • Central Nervous System Neoplasms (drug therapy, metabolism)
  • Female
  • Humans
  • Lymphoma (drug therapy, metabolism)
  • Male
  • Methotrexate (administration & dosage, adverse effects, analogs & derivatives, pharmacokinetics)
  • Middle Aged
  • Neoplasm Recurrence, Local (drug therapy)
  • Pilot Projects
  • gamma-Glutamyl Hydrolase (administration & dosage, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: